| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000261005.1 |
Bicalutamide |
Brain lower grade glioma |
0.002410504 |
Resistant |
| ENSG00000261005.1 |
Bicalutamide |
Pancreatic adenocarcinoma |
0.048404439 |
Resistant |
| ENSG00000261005.1 |
Bicalutamide |
Sarcoma |
0.025719835 |
Resistant |
| ENSG00000261005.1 |
Bicalutamide |
Skin cutaneous melanoma |
0.022682194 |
Resistant |
